Tempus AI is a technology company that focuses on advancing precision medicine by applying artificial intelligence ("AI') in healthcare. Co. uses AI to assist doctors and institutions in fighting cancer and other diseases. Co's platform includes proprietary software and dedicated data pipelines that create a network of healthcare institutions through approximately 450 unique data connections, many of which supply Co. with complex multimodal data in near real time, across more than 2,000 healthcare institutions that order Co.'s products and services. Co.'s products are organized under three product lines, Genomics, Data, and AI Applications or Algos. The TEM average annual return since 2024 is shown above.
The Average Annual Return on the TEM average annual return since 2024 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether TEM average annual return since 2024 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the TEM average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|